equol has been researched along with T-Cell Lymphoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cho, D; Kim, SH; Kim, TS; Park, J | 1 |
1 other study(ies) available for equol and T-Cell Lymphoma
Article | Year |
---|---|
Formononetin, a phyto-oestrogen, and its metabolites up-regulate interleukin-4 production in activated T cells via increased AP-1 DNA binding activity.
Topics: Animals; CD4-Positive T-Lymphocytes; Cells, Cultured; DNA-Binding Proteins; Equol; Humans; Interleukin-4; Isoflavones; Lymphocyte Activation; Lymphoma, T-Cell; Mice; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phytoestrogens; Protein Kinase C; T-Lymphocyte Subsets; Tetradecanoylphorbol Acetate; Transcription Factor AP-1; Tumor Cells, Cultured | 2005 |